Plain-English translation of NCT06674980 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether special patches made from human placental membrane—called AM/Single and AM/Double—can help heal diabetic foot ulcers and venous leg ulcers when used alongside standard wound care. These patches are designed to be placed on your wound to potentially speed up healing. Researchers want to know whether these patches work better than standard care by itself.
Many people with diabetes develop foot ulcers that don't heal well with standard treatments like dressings and offloading, and some leg ulcers are similarly stubborn. This trial exists to see whether adding the placental membrane patches to standard care can help these wounds close faster and more completely.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard wound care alone or standard wound care plus the placental membrane patches. If you receive the patches, they will be applied to your ulcer during your visits. You will need to attend weekly study visits for wound assessment and care, and you must follow the prescribed offloading method (a special boot for foot ulcers or compression wraps for leg ulcers) for the entire study. The researchers will measure your ulcer's progress over time to see if the patches help it heal better.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States